A. Eggebeen

Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.

N. Kaminski, C. Fuhrman, S. Yousem, 2009, Arthritis and rheumatism.

Non-thiolate ligation of nickel by nucleotide-free UreG of Klebsiella aerogenes

Andrew J. Head, D. Tellinghuisen, J. Birmingham, 2022 .

Long‐Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five‐Year Observational Study

R. Marcus, D. Furst, K. Dao, 2019, Arthritis Care & Research.

Gout: an update.

A. Eggebeen, 2007, American family physician.

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

Andrew I. Shulman, E. Janssen, M. Son, 2011, Arthritis and rheumatism.

Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Therapy in Rheumatoid Arthritis

Richard W. Martin, Andrew J. Head, D. Tellinghuisen, 2017, Medical decision making : an international journal of the Society for Medical Decision Making.

Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug

Richard W. Martin, Kelsey McCallops, Andrew J. Head, 2013, BMC Medical Informatics and Decision Making.

Long‐Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five‐Year Observational Study

D. Furst, K. Dao, M. Rosen, 2019, Arthritis care & research.

Characterization and Peripheral Blood Biomarker Assessment of Jo-1 Antibody-Positive Interstitial Lung Disease

K. Gibson, T. Richards, C. Oddis, 2011 .